About
Lygenesis develops clinical-stage cell therapies that use a patient’s lymph nodes as bioreactors to grow functional ectopic organs aimed at treating conditions like end stage liver disease, type 1 diabetes, and end stage renal disease.
Explore Lygenesis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.